Literature DB >> 33414070

Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.

Hannah C Zierden1, Aditya Josyula1, Rachel L Shapiro1, Henry T Hsueh1, Justin Hanes2, Laura M Ensign3.   

Abstract

The efficacy of drugs administered by traditional routes is limited by numerous biological barriers that preclude reaching the intended site of action. Further, full body systemic exposure leads to dose-limiting, off-target side effects. Topical formulations may provide more efficacious drug and nucleic acid delivery for diseases and conditions affecting mucosal tissues, but the mucus protecting our epithelial surfaces is a formidable barrier. Here, we describe recent advances in mucus-penetrating approaches for drug and nucleic acid delivery to the ocular surface, the female reproductive tract, the gastrointestinal tract, and the airways.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  drug delivery; mucoadhesive; mucoinert; mucus; mucus penetrating; nanomedicine

Mesh:

Year:  2021        PMID: 33414070      PMCID: PMC8087626          DOI: 10.1016/j.molmed.2020.12.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  99 in total

Review 1.  Mucoadhesive vs. mucopenetrating particulate drug delivery.

Authors:  Kesinee Netsomboon; Andreas Bernkop-Schnürch
Journal:  Eur J Pharm Biopharm       Date:  2015-11-17       Impact factor: 5.571

Review 2.  Real-time multiple-particle tracking: applications to drug and gene delivery.

Authors:  Junghae Suh; Michelle Dawson; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2005-01-02       Impact factor: 15.470

Review 3.  Spatial and temporal dynamics of the endothelium.

Authors:  W C Aird
Journal:  J Thromb Haemost       Date:  2005-05-09       Impact factor: 5.824

4.  Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study.

Authors:  Elena Yanushpolsky; Shelley Hurwitz; Louise Greenberg; Catherine Racowsky; Mark Hornstein
Journal:  Fertil Steril       Date:  2010-03-27       Impact factor: 7.329

5.  Side chain variations radically alter the diffusion of poly(2-alkyl-2-oxazoline) functionalised nanoparticles through a mucosal barrier.

Authors:  Edward D H Mansfield; Victor R de la Rosa; Radoslaw M Kowalczyk; Isabelle Grillo; Richard Hoogenboom; Katy Sillence; Patrick Hole; Adrian C Williams; Vitaliy V Khutoryanskiy
Journal:  Biomater Sci       Date:  2016-08-16       Impact factor: 6.843

6.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

7.  Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections.

Authors:  Carsten H Meyer; Stephan Michels; Eduardo B Rodrigues; Annette Hager; Stefan Mennel; Jörg C Schmidt; Hans-Martin Helb; Michel E Farah
Journal:  Acta Ophthalmol       Date:  2010-12-22       Impact factor: 3.761

8.  Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents.

Authors:  Travis J Good; Alan E Kimura; Naresh Mandava; Malik Y Kahook
Journal:  Br J Ophthalmol       Date:  2010-08-11       Impact factor: 4.638

9.  Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.

Authors:  Noha Nafee; Ayman Husari; Christine K Maurer; Cenbin Lu; Chiara de Rossi; Anke Steinbach; Rolf W Hartmann; Claus-Michael Lehr; Marc Schneider
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

View more
  8 in total

Review 1.  Next generation strategies for preventing preterm birth.

Authors:  Hannah C Zierden; Rachel L Shapiro; Kevin DeLong; Davell M Carter; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2021-04-23       Impact factor: 17.873

Review 2.  Application of Sol-Gels for Treatment of Gynaecological Conditions-Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery.

Authors:  Ritu Thapa; Shila Gurung; Marie-Odile Parat; Harendra S Parekh; Preeti Pandey
Journal:  Gels       Date:  2022-02-08

3.  Micro-ecology restoration of colonic inflammation by in-Situ oral delivery of antibody-laden hydrogel microcapsules.

Authors:  Bo Li; Xin Li; Xiaodong Chu; Pengcheng Lou; Yin Yuan; Aoxiang Zhuge; Xueling Zhu; Yangfan Shen; Jinghua Pan; Liyuan Zhang; Lanjuan Li; Zhongwen Wu
Journal:  Bioact Mater       Date:  2021-12-25

4.  Apparent Yield Stress of Sputum as a Relevant Biomarker in Cystic Fibrosis.

Authors:  Rosy Ghanem; Philippe Roquefort; Sophie Ramel; Véronique Laurent; Tanguy Haute; Tony Le Gall; Thierry Aubry; Tristan Montier
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

Review 5.  Ocular Nanomedicine.

Authors:  Zhimin Tang; Xianqun Fan; Yu Chen; Ping Gu
Journal:  Adv Sci (Weinh)       Date:  2022-02-12       Impact factor: 17.521

6.  Biological chemotaxis-guided self-thermophoretic nanoplatform augments colorectal cancer therapy through autonomous mucus penetration.

Authors:  Zhi-Hao Wang; Mengyu Chu; Na Yin; Wanting Huang; Wei Liu; Zhenzhong Zhang; Junjie Liu; Jinjin Shi
Journal:  Sci Adv       Date:  2022-06-29       Impact factor: 14.957

7.  Three-dimensional bioprinting of mucoadhesive scaffolds for the treatment of oral mucosal lesions; an in vitro study.

Authors:  Maryam Koopaie; Duha Hayder Mohammad Ali Nassar; Mahvash Shokrolahi
Journal:  3D Print Med       Date:  2022-09-28

8.  Sorafenib Nanomicelles Effectively Shrink Tumors by Vaginal Administration for Preoperative Chemotherapy of Cervical Cancer.

Authors:  Jun Wang; Fengmei Lv; Tao Sun; Shoujin Zhao; Haini Chen; Yu Liu; Zhepeng Liu
Journal:  Nanomaterials (Basel)       Date:  2021-12-01       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.